Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,400 | 23,100 | 33,300 | 24,200 | 12,300 |
| Receivables | 240,100 | 211,000 | 195,400 | 200,500 | 205,200 |
| Inventories | 214,700 | 155,200 | 135,500 | 110,200 | 135,700 |
| Income taxes - deferred | 35,700 | 41,800 | 42,800 | 36,900 | 37,200 |
| TOTAL | $552,400 | $483,500 | $497,300 | $410,600 | $429,200 |
| Non-Current Assets | |||||
| PPE Net | 85,800 | 74,500 | 71,400 | 61,800 | 53,100 |
| Intangibles | 579,900 | 561,200 | 501,200 | 419,100 | 391,300 |
| Other Non-Current Assets | 81,400 | 32,400 | 4,100 | 9,300 | 12,700 |
| TOTAL | $747,100 | $668,100 | $576,700 | $490,200 | $457,100 |
| Total Assets | $1,299,500 | $1,151,600 | $1,074,000 | $900,800 | $886,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15,600 | 11,600 | 6,300 | 12,500 | 12,500 |
| Accounts payable and accrued liabilities | 107,100 | 71,700 | 96,000 | 78,800 | 49,700 |
| Accrued Expenses | 32,500 | 30,600 | 35,100 | 38,700 | 35,800 |
| TOTAL | $182,300 | $141,400 | $178,200 | $151,000 | $107,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 457,800 | 413,600 | 344,400 | 218,800 | 303,000 |
| Other Non-Current Liabilities | 88,700 | 56,500 | 57,600 | 49,800 | 22,500 |
| TOTAL | $573,000 | $490,800 | $417,700 | $287,300 | $336,600 |
| Total Liabilities | $755,300 | $632,200 | $595,900 | $438,300 | $443,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,790 | 30,517 | 30,154 | 29,718 | 29,542 |
| Common Shares | 300 | 300 | 300 | 300 | 300 |
| Retained earnings | 173,700 | 152,100 | 117,000 | 110,200 | 91,300 |
| Other shareholders' equity | 100 | 400 | -300 | -200 | 0 |
| TOTAL | $544,200 | $519,400 | $478,100 | $462,500 | $442,600 |
| Total Liabilities And Equity | $1,299,500 | $1,151,600 | $1,074,000 | $900,800 | $886,300 |